Research programme: CC-chemokine receptor 3 antagonists - Astellas Pharma/Toray Industries
Alternative Names: YM-344484; YM-355179Latest Information Update: 16 Jul 2016
At a glance
- Originator Astellas Pharma; Toray
- Class
- Mechanism of Action CCR3 receptor antagonists; Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in Japan (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Japan (PO)
- 09 Aug 2006 Preclinical trials in Inflammation in Japan (PO)